or
forgot password

    • cancer clinical trials in new port richey, FL

    • Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)
    Advanced Research Institute
    New Port Richey, Florida 34652
    Preneoplastic Conditions, Prostatic Intraepithelial Neoplasia
    Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer
    Advanced Research Institute, Inc.
    New Port Richey, Florida 34652
    Prostate Cancer
    Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
    Advance Research Institute
    New Port Richey, Florida 34652
    Prostate Cancer, Osteoporosis, Fractures
    Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Pasco Hernando Oncology Associates, PA
    New Port Richey, Florida 34642
    Carcinoma, Non-Small Cell Lung
    Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
    Florida Cancer Institute
    New Port Richey, Florida 34652
    Colorectal Cancer Metastatic
    DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
    Florida Cancer Institute

    Trial Locations
    Florida Cancer Institute
    Pasco Hernando Oncology Associates P.A.
    Prostate Cancer
    Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters
    Pasco Hernando Oncology Associates

    Trial Locations
    Pasco Hernando Oncology Associates
    Pasco Hernando Oncology Associate
    Thrombosis, Venous Thrombosis, Catheter Occlusion
    Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer
    Pasco Hernando Oncology
    New Port Richey, Florida 34652
    Non-small Cell Lung Cancer
    A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma
    Pasco Hernando Oncology Associates
    New Port Richey, Florida 34652
    Lymphoma, Non-Hodgkin's
    Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
    Florida Cancer Institute
    New Port Richey, Florida 34652
    Chronic Idiopathic Thrombocytopenic Purpura, Purpura, Thrombocytopenic, Idiopathic
    Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
    Florida Cancer Institute
    New Port Richey, Florida 34652
    Metastatic Breast Cancer
    Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients
    Advanced Research Institute
    New Port Richey, Florida 34652
    Prostate Cancer
    A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)
    Florida Cancer Institute
    New Port Richey, Florida 34652
    Extensive-stage Small Cell Lung Cancer
    Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
    Pasco Pinellas Cancer Center
    New Port Richey, Florida 34652
    Non Small Cell Lung Cancer
    Platinum Resistant Ovarian Cancer Evaluation of Doxil and EC145 Combination Therapy
    Pasco Pinellas Cancer Center
    New Port Richey, Florida 34652
    Ovarian Cancer
    Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer
    Advanced Research Institute, Inc.
    New Port Richey, Florida 34652
    Superficial Bladder Cancer
    A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases
    Florida Cancer Institute - New Hope
    New Port Richey, Florida 34655
    Metastatic Non-Small Cell Lung Cancer
    To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.
    Pasco Pinellas Cancer Center
    New Port Richey, Florida 34652
    Myelodysplastic Syndromes
    Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
    Advanced Research Institute, Inc.
    New Port Richey, Florida 34652
    Bladder Neoplasm, Intravesical Drug Administration, Neoplasm Recurrence, Local, Transitional Cell, Carcinoma, Carcinoma in Situ, Mycobacterium